Could myeloma patients skip the hospital stay? new study tests outpatient drug dosing
NCT ID NCT05972135
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 32 times
Summary
This study tests whether two multiple myeloma drugs, teclistamab and talquetamab, can be given safely in an outpatient clinic instead of requiring a hospital stay. About 100 adults with multiple myeloma who have tried at least one prior treatment will receive preventive medicine to reduce side effects like cytokine release syndrome (CRS). The goal is to see if this approach lowers the risk of serious reactions and makes treatment more convenient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arizona Oncology Associates
RECRUITINGTucson, Arizona, 85711, United States
-
Blue Ridge Cancer Center
RECRUITINGRoanoke, Virginia, 24014, United States
-
Colorado Blood Cancer Institute
RECRUITINGDenver, Colorado, 80218, United States
-
Florida Cancer Specialists
WITHDRAWNLake Mary, Florida, 32746, United States
-
Maryland Oncology Hematology
RECRUITINGColumbia, Maryland, 21044, United States
-
Medical Oncology Hematology Consultants
RECRUITINGNewark, Delaware, 19713, United States
-
Minnesota Oncology Hematology
RECRUITINGMinneapolis, Minnesota, 55404, United States
-
Oncology Associates of Oregon
RECRUITINGEugene, Oregon, 97401, United States
-
Oncology Hematology Care
RECRUITINGCincinnati, Ohio, 45242, United States
-
Rocky Mountain Cancer Center
RECRUITINGDenver, Colorado, 80218, United States
-
Texas Oncology
RECRUITINGAustin, Texas, 78705, United States
-
Texas Oncology - Northeast Texas
RECRUITINGTyler, Texas, 75702, United States
-
Texas Oncology - San Antonio
RECRUITINGSan Antonio, Texas, 78240, United States
-
TriStar Bone Marrow Transplant
RECRUITINGNashville, Tennessee, 37203, United States
-
Vanderbilt- Ingram Cancer Center
RECRUITINGNashville, Tennessee, 37232, United States
-
Virginia Cancer Specialists
RECRUITINGFairfax, Virginia, 22031, United States
-
Virginia Oncology Associates
RECRUITINGElizabeth City, North Carolina, 27909, United States
Conditions
Explore the condition pages connected to this study.